Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma
J. Chu, X. Niu, J. Chang…·C. Wu
This study identifies TIGAR as a driver of metabolic remodeling in ESCC, showing that targeting the glutamine pathway improves therapeutic outcomes in TIGAR-overexpressed tumors.